Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Glucagon-like peptide-1 receptor agonists for obesity
Improve your sleep and manage stress Good metabolic health is about more than food and exercise
For instance, in March 2024, the World Obesity Federation reported that over 650 million adults are obese globally, increasing demand for weight management treatments like semaglutide
When you work with a provider like QuickMD to help you meet your weight loss goals, it can help reduce the cost of traditional doctor visits
The state Office of the Health Insurance Commissioner wrote in a report in May that spending on GLP-1s such as Ozempic, Weygovy, Mounjaro and Zepbound "nearly tripled" from 2021 to 2023 and was the "primary driver" behind a 7.8% increase in total health care spending in 2023
.jpg)
